Putting the treaty against counterfeit medicines under the auspices of the UN Office of Drugs and Crime is on balance with a poor idea. WHO is, for now, still the best institution under which to negotiate and achieve a treaty for improving the quality of medicines.

The counterfeiting of medicines is so prevalent yet totally unaddressed and therefore legal in international criminal law. A counterfeit medicine treaty should be drafted under the auspices of the World Health Organization.

The intent behind a proposed treaty to criminalize the manufacture and trade in counterfeited drugs is good, but only a treaty initiated by the World Health Organization will suffice.

Ending the use of DDT in malarious areas may pose great risks to the health and welfare of people and would be based on flawed analysis.

Can the shelf-life of fixed dose combination artemether-lumefantrine be extended?

The drug regulatory system in India needs to be improved for domestic consumption and because India is an increasingly important exporter of drugs for both developed and developing countries.

The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies inAfrica risks patient safety and endangers the future of malaria treatment.

Why ignore theWorld Health Organization's medical advice?